As cigarette smoking continues its decades-long decline across much of the Western world, a growing divide is emerging between tobacco harm reduction advocates and public health organisations determined to eliminate nicotine use altogether. Recent US developments in Arkansas, Arizona, Massachusetts and beyond suggest that this conflict is no longer simply about smoking. Increasingly, it is about whether policymakers are willing to distinguish between combustible tobacco and significantly lower-risk nicotine alternatives.
The debate is striking since many policies are being pushed even though youth smoking rates are at historic lows. Instead of further decreasing adult cigarette use, regulators and advocacy groups are now increasingly focusing on nicotine products many former smokers use as alternatives.
A growing divide in tobacco control
Arkansas serves as a telling example. Tobacco control advocates have frequently criticised the state for its lack of stricter regulations on vaping products and flavours. In 2023, Arkansas received a failing grade from the American Lung Association concerning tobacco prevention funding, with campaigners arguing that tougher regulations were needed to address youth nicotine use.
However, the state’s Youth Risk Behaviour Survey (YRBS) presents a more complex story. Although youth vaping has received a lot of media attention, the long-term trend shows that teenage smoking has been on a steady decline. Vaping rates also declined significantly between 2019 and 2021. Daily vaping among high school students decreased by 60 per cent, while past-month usage nearly halved. These figures raise important questions: If both youth smoking and vaping rates are dropping, what’s fueling this obsession for tougher nicotine regulations?
Arizona offers another example of this growing disconnect. The state’s latest tobacco control assessment once again delivered failing grades for prevention funding, tobacco taxation and flavour restrictions. Advocacy groups responded by calling for higher taxes, more spending and tighter regulations.
What are lawmakers really after?
The current emphasis on overly harsh measures reveals a broader, newer trend in tobacco control. Instead of determining success by how many smokers actually quit combustible tobacco, the focus is largely on the number of restrictions enforced, regardless of whether these prove effective. Established researchers in the field of tobacco harm reduction are warning that this approach is shifting attention away from the real public health aim: reducing smoking-related illnesses and deaths.
In Massachusetts, this issue has really caught people’s attention, especially since several towns have now put in place generational bans, preventing anyone born after a set date from ever being able to buy nicotine products legally. These measures have sparked strong debates. Supporters describe the policies as innovative public health interventions designed to prevent future addiction. But once again, many are questioning the need for harsher nicotine regulations when rates of youth smoking and vaping are actually declining.
Moreover, investigative reporting published this year raised questions about the extent to which publicly funded advocacy networks and tobacco control organisations coordinated efforts to advance these measures through local boards of health. A report points to significant increases in budgets for certain advocacy organisations and describes networks of state-supported public health groups as influential in shaping the adoption of local policies. Amongst other things, these organisations provide legal and administrative support to municipalities considering NFG rules, including model ordinances and implementation guidance.
Opting for strategies which have failed in the past
Sadly, such policies also signal a broader change in the approach to tobacco control. A recent article published by the Cleveland Clinic sparked a lot of criticism from researchers and the tobacco harm reduction community, because it presented vaping and smoking as carrying more or less the same risks. Critics described the article as a classic example of false equivalence, warning that such messaging risks confusing smokers about the relative dangers of different nicotine products.
The scientific distinction is not trivial. Decades of research have consistently shown that the overwhelming health risks associated with smoking stem from inhaling toxic chemicals produced by burning tobacco. Nicotine is addictive, but it is not the primary cause of smoking-related cancers, chronic obstructive pulmonary disease (COPD) or most cardiovascular damage linked to cigarettes.
Dismissing existing sound evidence
This principle has been recognised by leading scientific bodies for years. The Royal College of Physicians concluded that smokers consume cigarettes for nicotine but die from the products of combustion. Its landmark harm reduction reports argued that providing access to substantially safer nicotine alternatives could save millions of lives.
The same conclusion has been reiterated by numerous clinical studies. Randomised controlled trials published in the New England Journal of Medicine found vaping products outperform traditional nicotine replacement therapies (NRTs) in helping smokers quit. Similar evidence has emerged for nicotine pouches, which deliver nicotine without tobacco, smoke, or vapour. Many media stories focus on youth uptake and consumption, as well as the availability of attractive flavours. Moreover, headlines like to paint nicotine pouches as a sneaky strategy by tobacco companies to attract new users, totally overlooking how these products can help smokers move away from traditional cigarettes.
The reluctance to acknowledge that smoke-free alternatives, though not completely without risk, generally expose users to much lower amounts of harmful substances is hard to reconcile with real-world evidence. Sweden, which embraced smoke-free nicotine products like snus and nicotine pouches, became the first nation to achieve official smoke-free status. It also has some of the lowest smoking-related disease rates in Europe.
Should the end justify the means?
Despite this success, many tobacco control organisations continue to advocate policies centred on prohibition, flavour bans, taxation and restrictions rather than encouraging smokers to switch to lower-risk alternatives. The result is an increasingly polarised debate. On one side are those who view nicotine use itself as the primary problem. On the other are those who argue that public health should focus on reducing disease by encouraging smokers to move away from combustion.
The experiences of Arkansas, Arizona and Massachusetts suggest that this conflict is likely to intensify in the coming years. As youth smoking reaches record lows and safer nicotine products become more widely available, policymakers will face a fundamental choice.
They can continue pursuing a nicotine-free society through tighter restrictions and prohibitions, or embrace a harm reduction framework that recognises an important reality: while eliminating nicotine use may be admirable, reducing smoking-related death and disease should remain the priority. For millions of smokers unable or unwilling to quit nicotine altogether, that distinction could prove lifesaving.
